The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing
2 April 2025 By Eurofins Discovery
Explore how a Weight of Evidence (WoE) approach uses in vitro methods and artificial intelligence (AI) to transform carcinogenicity risk assessment, reducing reliance on animal studies while enhancing compliance with FDA and ICH guidelines.